Dispatches from a Pandemic: Johnson & Johnson and AstraZeneca clot issues are not unexpected — it would be more unusual to have no vaccine problems
‘It was a wise decision to spread the risk. Factories can be hit by a hurricane, run out of a supply, or be hit by contamination that forces them to shut down.’
